Paper31875848
Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis.
Song X and 10 others. Nature, 2020. Cited by 885 papers, by iCite.
Cite this record
ConductScience Library. Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis. Papers, record 31875848. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31875848
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bile Acids and Salts | Major topic |
| Gastrointestinal Microbiome | Major topic |
| Homeostasis | Major topic |
| Intestines | Major topic |
| Nuclear Receptor Subfamily 1, Group F, Member 3 | Major topic |
| T-Lymphocytes, Regulatory | Major topic |
| Animals | |
| Mice, Inbred C57BL |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K01 DK102771 | NIDDK NIH HHS | United States | K01DK102771 | PubMed and NIH | NIH RePORTER |
| R01 AI125603 | NIAID NIH HHS | United States | R01AI125603 | PubMed | NIH RePORTER |
| R01 AT010268 | NCCIH NIH HHS | United States | R01AT010268 | PubMed | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 32130878 | Microbiome Modulation of the Host Adaptive Immunity through Bile Acid Modification. | https://conductscience.org/library/papers/32130878 |
Source PubMed
Cited by667
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 885 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42979195 | The gut-placental axis: microbial signals remodeling maternal-fetal immune tolerance. | Front Immunol | 2026 | https://conductscience.org/library/papers/42979195 | PubMed |
| 42967594 | The microbiome and brain metastasis in non-small cell lung cancer: A graded appraisal and a framework for prevention-oriented research. | Clin Transl Med | 2026 | https://conductscience.org/library/papers/42967594 | PubMed |
| 42943554 | Bifidobacterium longum Depletion and Bile Acid Dysregulation in MASLD: Links to Hepatic TGR5-AMPK Signaling. | Microorganisms | 2026 | https://conductscience.org/library/papers/42943554 | PubMed |
| 42926400 | Cholera toxin remodels intestinal immunity and suppresses systemic metabolism. | bioRxiv | 2026 | https://conductscience.org/library/papers/42926400 | PubMed |
| 42921202 | Microbiota-Associated Metabolites as Immunometabolic Regulators of Glomerular Inflammation: Disease-Specific Mechanisms and Therapeutic Opportunities. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42921202 | PubMed |
| 42921032 | Gut microbiota-immune-bone axis in osteoporosis: mechanisms and intervention strategies. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42921032 | PubMed |
| 42904172 | Crosstalk between gut microbiota-associated metabolites and adaptive immunity in cholecystitis: a conceptual mechanistic framework and potential therapeutic implications. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42904172 | PubMed |
| 42898941 | Gut microbiota and innate immune barrier dysfunction in hepatic portal venous gas: a hypothesis-generating review. | Front Immunol | 2026 | https://conductscience.org/library/papers/42898941 | PubMed |
| 42889669 | The microbiome-metabolite-vaccine axis: context-dependent modulators of immunogenicity and durability. | Front Immunol | 2026 | https://conductscience.org/library/papers/42889669 | PubMed |
| 42889440 | Oleanolic acid-derived triterpenoids with dual TGR5 agonistic and RORγ inverse agonistic activity. | RSC Med Chem | 2026 | https://conductscience.org/library/papers/42889440 | PubMed |
| 42883044 | Gut Microbiota-Mucosal Immune Interactions Underlying Intestinal Homeostasis in Weaned Piglets. | Animals (Basel) | 2026 | https://conductscience.org/library/papers/42883044 | PubMed |
| 42874562 | Pleiotropic roles of microbial bile acid metabolism in intestinal health and diseases. | Cell Host Microbe | 2026 | https://conductscience.org/library/papers/42874562 | PubMed |
| 42850871 | Role of Bile Acid Receptors in Non-Infectious Diarrhea: A Narrative Review. | Med Sci Monit | 2026 | https://conductscience.org/library/papers/42850871 | PubMed |
| 42825856 | Bile acid signaling in health and disease. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42825856 | PubMed |
| 42824782 | Vitamin D and gut microbiota in thyroid diseases: mechanisms and therapeutic potential. | Front Immunol | 2026 | https://conductscience.org/library/papers/42824782 | PubMed |
| 42809189 | Immunomodulatory Function of Soluble Dietary Fiber: Toward Application for Prevention and Treatment of Food Allergies. | Curr Allergy Asthma Rep | 2026 | https://conductscience.org/library/papers/42809189 | PubMed |
| 42781741 | Expanding bile acid diversity via host and microbial conjugation pathways. | Nat Prod Rep | 2026 | https://conductscience.org/library/papers/42781741 | PubMed |
| 42762950 | Metabolic Dysfunction-Associated Steatohepatitis: Is There Evidence for Fractured CD4+ T-Cell Tolerance in the Immunopathogenesis. | Cell Mol Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/42762950 | PubMed |
| 42729556 | Gut microbiota dysbiosis in rheumatoid arthritis: mechanisms linking intestinal barrier dysfunction to synovial inflammation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42729556 | PubMed |
| 42726156 | HDCA suppresses exosomal lncRNA MSTRG171708 release to inhibit Treg-mediated immunometabolism in hepatocellular carcinoma. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42726156 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FOXP3 | 50943 | PubTator's text mining | https://conductscience.org/library/genes/50943 | NCBI Gene |
| GPR3 | 2827 | PubTator's text mining | https://conductscience.org/library/genes/2827 | NCBI Gene |
| GPR4 | 2828 | PubTator's text mining | https://conductscience.org/library/genes/2828 | NCBI Gene |
| RORC | 6097 | PubTator's text mining | https://conductscience.org/library/genes/6097 | NCBI Gene |
| VDR | 7421 | PubTator's text mining | https://conductscience.org/library/genes/7421 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31875848
GET https://conductscience.org/api/papers/v1/31875848/cited_by?page=2